MDL 72527

Known as: MDL-72527, MDL-72527DA 
 

Topic mentions per year

Topic mentions per year

1985-2016
012319852016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND/AIMS The polyamine oxidase inhibitor MDL-72527 (N1,N4-bis(2,3-butadienyl)-1,4-butanediamine) were expected to increase… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2009
2009
It has been confirmed that multidrug resistant (MDR) human melanoma cells are more sensitive than their wild-type counterparts to… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
2006
2006
In situ formation of cytotoxic metabolites by an enzyme-catalyzed reaction is a recent approach in cancer chemotherapy. We… (More)
Is this relevant?
2006
2006
Apple procyanidins have chemopreventive properties in a model of colon cancer, they affect intracellular signalling pathways, and… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 6
  • figure 4
Is this relevant?
2006
2006
MDL 72527 was considered a selective inhibitor of FAD-dependent polyamine oxidases. In the present communication, we demonstrate… (More)
Is this relevant?
2005
2005
Murine N(1)-acetylated polyamine oxidase (mPAO) was treated with N,N'-bis-(prop-2-ynyl)-1,4-diaminobutane, a poor substrate and… (More)
Is this relevant?
2005
2005
MDL 72527 (N1,N4-di-2,3-butadienyl-1,4-butanediamine) is a selective inactivator of polyamine oxidase with therapeutic potential… (More)
Is this relevant?
2002
2002
N 1,N 4-bis(2,3-butadienyl)-1,4-butanediamine (MDL 72527) was considered to be a selective inactivator of FAD-dependent tissue… (More)
Is this relevant?
2000
2000
N(1)-(n-octanesulfonyl)spermine (N(1)OSSpm) is a potent calmodulin antagonist. In the present work, its toxicity to DHD/K12/TRb… (More)
Is this relevant?
1999
1999
The possible effects of the polyamine interconversion pathway on tissue polyamine levels, brain edema formation, and ischemic… (More)
Is this relevant?